A Qualitative Approach to a Better Understanding of the Problems Underlying Drug Shortages, as Viewed from Belgian, French and the European Union’s Perspectives

Abstract

The problem of drug shortages has been reported worldwide, gaining prominence in multiple domains and several countries in recent years. The aim of the study was to analyze, characterise and assess this problem in Belgium and France, while also adopting a wider perspective from the European Union. A qualitative methodological approach was employed, including semi-structured interviews with the representatives of respective national health authorities, pharmaceutical companies and wholesalers, as well as hospital and community pharmacists. The research was conducted in early 2014. Four themes, which were identified through the interviews, were addressed in the paper, i.e. a) defining drug shortages, b) their dynamics and perception, c) their determinants, d) the role of the European and national institutions in coping with the problem. Three groups of determinants of drug shortages were identified throughout this study: manufacturing problems, distribution and supply problems, and problems related to economic aspects. Currently, the Member States of the European Union are striving to resolve the problem very much on their own, although a far more focused and dedicated collaboration may well prove instrumental in coping with drug shortages throughout Europe more effectively. To the best of the authors’ knowledge, this is the first qualitative study to investigate the characteristics, key determinants, and the problem drivers of drug shortages, focusing on this particular group of countries, while also adopting the European Union’s perspective.

The reasons behind medicine shortages from the perspective of pharmaceutical companies and pharmaceutical wholesalers in Finland

“…Thus, the results of our study support the earlier hypothesis that the lack of market attractiveness is a major root cause of medicine shortages [4, 17–18, 49]. This may be due to the fact that the pharmaceutical industry’s operating costs have grown significantly in the past ten years and the industry has become more reluctant to market medicines [21]. This has led to medicine shortages in less attractive markets globally.…”

It is important that the process goes quickly, isn't it?” A qualitative multi-country study of colorectal or lung cancer patients' narratives of the timeliness of diagnosis and quality of care

“…Cross-country research has the potential to enhance understanding of health and illness between counties, however there are potential barriers that needs to be addressed to ensure comparability. It has been pointed out that in cross country research the researchers needs to understand the context within the different countries where the research takes place (Haak et al, 2013) and that it is important that the they agree on the meaning of key concepts and terminology to avoid discrepancy (Bogaert, et al, 2015). To ensure comparability potential hinders were identified and addressed during the process of developing the topic guide.…”

Current Situation, Determinants, and Solutions to Drug Shortages in Shaanxi Province, China: A Qualitative Study

“…Several researchers exploring drug shortages in the US investigated its scope, causes, impact, and solutions [3,9,13]. Reports about shortages of medicines in Europe concentrated on the scope and causes [14–16]. Recently, drug shortages in Canada were also discussed and the related reasons were analyzed [17–19].…”